Humanoid, Inc. (HERB)

Humanoid Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	24.15	21.14	18.59	14.01	12.55
Revenue Growth (YoY)	14.25%	13.71%	32.64%	11.68%	-98.66%
Cost of Revenue	16.07	14.1	13	10	9.31
Gross Profit	8.08	7.04	5.59	4.01	3.24
Selling, General & Admin	0.88	0.78	0.68	0.56	0.5
Operating Expenses	0.88	0.78	0.68	0.56	0.5
Operating Income	7.2	6.26	4.91	3.46	2.74
Interest Expense	-0.01	-0	-0	-0	-0
Other Non Operating Income (Expenses)	0.87	0.76	0.4	0.26	0.25
Pretax Income	8.07	7.02	5.31	3.72	2.99
Net Income	8.07	7.02	5.31	3.72	2.99
Net Income to Common	8.07	7.02	5.31	3.72	2.99
Net Income Growth	15.00%	32.21%	42.78%	24.27%	-97.33%
Shares Outstanding (Basic)	157	157	157	157	157
Shares Outstanding (Diluted)	157	157	157	157	157
EPS (Basic)	0.05	0.04	0.03	0.02	0.02
EPS (Diluted)	0.05	0.04	0.03	0.02	0.02
EPS Growth	15.00%	32.21%	42.78%	24.26%	-97.33%
Free Cash Flow	2.74	2.72	0.4	1.94	-0.89
Free Cash Flow Per Share	0.02	0.02	0.00	0.01	-0.01
Gross Margin	33.46%	33.31%	30.06%	28.64%	25.82%
Operating Margin	29.81%	29.62%	26.41%	24.67%	21.84%
Profit Margin	33.41%	33.20%	28.55%	26.52%	23.84%
Free Cash Flow Margin	11.34%	12.87%	2.15%	13.84%	-7.08%
EBITDA	7.66	6.66	5.21	3.76	3.02
EBITDA Margin	31.72%	31.49%	28.02%	26.81%	24.05%
D&A For EBITDA	0.46	0.4	0.3	0.3	0.28
EBIT	7.2	6.26	4.91	3.46	2.74
EBIT Margin	29.81%	29.62%	26.41%	24.67%	21.84%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.